Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine ; volume:12 ; number:1 ; day:7 ; month:11 ; year:2012 ; pages:1-11 ; date:12.2012
BMC cancer ; 12, Heft 1 (7.11.2012), 1-11, 12.2012
- Creator
-
Hutzen, Brian
- Contributor
-
Pierson, Christopher R.
Russell, Stephen J.
Galanis, Evanthia
Raffel, Corey
Studebaker, Adam W.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-12-508
- URN
-
urn:nbn:de:1111-201603041086
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hutzen, Brian
- Pierson, Christopher R.
- Russell, Stephen J.
- Galanis, Evanthia
- Raffel, Corey
- Studebaker, Adam W.
- SpringerLink (Online service)
Other Objects (12)
Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Using TGF-β1 biology in radioiodine refractory differentiated thyroid cancer to re-establish sodium iodide symporter (NIS) expression using engineered mesenchymal stem cells as therapy vehicles
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer
Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Using TGF-β1 biology in radioiodine refractory differentiated thyroid cancer to re-establish sodium iodide symporter (NIS) expression using engineered mesenchymal stem cells as therapy vehicles
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer
Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Using TGF-β1 biology in radioiodine refractory differentiated thyroid cancer to re-establish sodium iodide symporter (NIS) expression using engineered mesenchymal stem cells as therapy vehicles
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells